oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Cord serum lipidome in prediction of islet autoimmunity and type 1 diabetes
Örebro University, School of Medical Sciences. VTT Technical Research Centre of Finland, Espoo, Finland.ORCID iD: 0000-0002-2856-9165
VTT Technical Research Centre of Finland, Espoo, Finland.
Department of Pediatrics, University of Turku, Turku, Finland; Hospital District of Southwest Finland, Turku, Finland.
VTT Technical Research Centre of Finland, Espoo, Finland.
Show others and affiliations
2013 (English)In: Diabetes, ISSN 0012-1797, E-ISSN 1939-327X, Vol. 62, no 9, p. 3268-3274Article in journal (Refereed) Published
Abstract [en]

Previous studies show that children who later progress to type 1 diabetes (T1D) have decreased preautoimmune concentrations of multiple phospholipids as compared with nonprogressors. It is still unclear whether these changes associate with development of β-cell autoimmunity or specifically with clinical T1D. Here, we studied umbilical cord serum lipidome in infants who later developed T1D (N = 33); infants who developed three or four (N = 31) islet autoantibodies, two (N = 31) islet autoantibodies, or one (N = 48) islet autoantibody during the follow-up; and controls (N = 143) matched for sex, HLA-DQB1 genotype, city of birth, and period of birth. The analyses of serum molecular lipids were performed using the established lipidomics platform based on ultra-performance liquid chromatography coupled to mass spectrometry. We found that T1D progressors are characterized by a distinct cord blood lipidomic profile that includes reduced major choline-containing phospholipids, including sphingomyelins and phosphatidylcholines. A molecular signature was developed comprising seven lipids that predicted high risk for progression to T1D with an odds ratio of 5.94 (95% CI, 1.07-17.50). Reduction in choline-containing phospholipids in cord blood therefore is specifically associated with progression to T1D but not with development of β-cell autoimmunity in general.

Place, publisher, year, edition, pages
American Diabetes Association , 2013. Vol. 62, no 9, p. 3268-3274
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:oru:diva-63682DOI: 10.2337/db13-0159ISI: 000323421000035PubMedID: 23630305Scopus ID: 2-s2.0-84883230213OAI: oai:DiVA.org:oru-63682DiVA, id: diva2:1169248
Funder
EU, FP7, Seventh Framework Programme, HEALTH-F2-2008-202013
Note

Funding agencies:

Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research) 250114 

Juvenile Diabetes Research Foundation 36-2008-919 

Available from: 2017-12-22 Created: 2017-12-22 Last updated: 2018-01-30Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records BETA

Oresic, MatejHyötyläinen, Tuulia

Search in DiVA

By author/editor
Oresic, MatejHyötyläinen, Tuulia
By organisation
School of Medical SciencesSchool of Science and Technology
In the same journal
Diabetes
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 48 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf